Fennec Pharmaceuticals (FENC) Operating Margin (2020 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Operating Margin came in at 18.54% in Q4 2025, down 675.0% YoY from 3.22% in Q4 2024, and down 1122.34% on a QoQ basis from 1.52% in Q3 2025.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) Operating Margin (2020 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 4 years of Operating Margin data on file, last reported at 18.54% in Q4 2025.
- Quarterly Operating Margin fell 675.0% year-over-year to 18.54% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 14.07% (down 1948.0% YoY) and the FY2025 annual result came in at 14.07%, down 1947.0% from the prior year.
- Operating Margin slipped to 18.54% in Q4 2025, from 1.52% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 54.16% in Q1 2024 to a low of 314.25% in Q1 2023.
- A 3-year average of 54.01% and a median of 18.61% in 2023 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2024 — Operating Margin jumped 36841 bps — and 2025, when it plunged 6339 bps.
- Tracing FENC's Operating Margin over 3 years: stood at 18.67% in 2023, then jumped by 37 bps to 11.79% in 2024, then slumped by 57 bps to 18.54% in 2025.
- The last three Operating Margin figures came in at 18.54% (Q4 2025), 1.52% (Q3 2025), and 28.31% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -562.07% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.06% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 17.93% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.75% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.36% |
| 10 | Fennec Pharmaceuticals | 432.85 Mn | 391.60 Mn | 17.15 Mn | 9.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.72% |
| Dec 31, 2025 | -18.54% |
| Sep 30, 2025 | -1.52% |
| Jun 30, 2025 | -28.31% |
| Mar 31, 2025 | -9.23% |
| Dec 31, 2024 | -11.79% |
| Sep 30, 2024 | -74.59% |
| Jun 30, 2024 | -69.39% |
| Mar 31, 2024 | 54.16% |
| Dec 31, 2023 | -18.67% |
| Sep 30, 2023 | -15.61% |
| Jun 30, 2023 | -140.33% |
| Mar 31, 2023 | -314.25% |
| Dec 31, 2020 | -1,673.00% |